The clinical presentation of individuals with DJ1 mutations is characterized by early onset slow progressing parkinsonism, which is frequently accompanied by non-motor symptomatology (e.g., anxiety, cognitive decline, and psychotic symptoms), and good L-DOPA responsiveness [142]. Here, PARK7 is linked to Parkinsonism.